Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with type 2 diabetes~* Current treatment using intermediate-acting, long-acting insulin (including long-acting insulin analogue) or pre-mixed human insulin for at least 24 weeks~* HbA1c at least 7.5% and below 10.0%~Exclusion Criteria:~* Proliferative retinopathy or maculopathy requiring acute treatment~* Impaired hepatic and/or renal function~* Cardiac diseases~* Uncontrolled hypertension~* Known hypoglycemia unawareness or recurrent major hypoglycemia

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).